These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25881901)

  • 1. Temporal and spatial characteristics of the area at risk investigated using computed tomography and T1-weighted magnetic resonance imaging.
    van der Pals J; Hammer-Hansen S; Nielles-Vallespin S; Kellman P; Taylor J; Kozlov S; Hsu LY; Chen MY; Arai AE
    Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1232-40. PubMed ID: 25881901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction.
    Ugander M; Bagi PS; Oki AJ; Chen B; Hsu LY; Aletras AH; Shah S; Greiser A; Kellman P; Arai AE
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):596-603. PubMed ID: 22698528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Gadolinium Enhancement for Determination of Area at Risk: A Preclinical Validation Study.
    Hammer-Hansen S; Leung SW; Hsu LY; Wilson JR; Taylor J; Greve AM; Thune JJ; Køber L; Kellman P; Arai AE
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):130-139. PubMed ID: 27665165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury.
    Hansen ESS; Pedersen SF; Pedersen SB; Bøtker HE; Kim WY
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1039-1045. PubMed ID: 30852704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction.
    Tilak GS; Hsu LY; Hoyt RF; Arai AE; Aletras AH
    Invest Radiol; 2008 Jan; 43(1):7-15. PubMed ID: 18097272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardium at risk in ST-segment elevation myocardial infarction comparison of T2-weighted edema imaging with the MR-assessed endocardial surface area and validation against angiographic scoring.
    Fuernau G; Eitel I; Franke V; Hildebrandt L; Meissner J; de Waha S; Lurz P; Gutberlet M; Desch S; Schuler G; Thiele H
    JACC Cardiovasc Imaging; 2011 Sep; 4(9):967-76. PubMed ID: 21920334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the myocardial area at risk: comparing T2-weighted cardiovascular magnetic resonance imaging with contrast-enhanced cine (CE-SSFP) imaging-a DANAMI3 substudy.
    Göransson C; Ahtarovski KA; Kyhl K; Lønborg J; Nepper-Christensen L; Bertelsen L; Ghotbi AA; Schoos MM; Køber L; Høfsten D; Helqvist S; Kelbæk H; Engstrøm T; Vejlstrup N
    Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):361-366. PubMed ID: 30085055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction.
    Nordlund D; Kanski M; Jablonowski R; Koul S; Erlinge D; Carlsson M; Engblom H; Aletras AH; Arheden H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):12. PubMed ID: 28132648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model.
    Mewton N; Rapacchi S; Augeul L; Ferrera R; Loufouat J; Boussel L; Micolich A; Rioufol G; Revel D; Ovize M; Croisille P
    Basic Res Cardiol; 2011 Nov; 106(6):1247-57. PubMed ID: 21874556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography.
    Wright J; Adriaenssens T; Dymarkowski S; Desmet W; Bogaert J
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):825-31. PubMed ID: 19608131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative high resolution voxel-wise assessment of myocardial blood flow from contrast-enhanced first-pass magnetic resonance perfusion imaging: microsphere validation in a magnetic resonance compatible free beating explanted pig heart model.
    Schuster A; Sinclair M; Zarinabad N; Ishida M; van den Wijngaard JP; Paul M; van Horssen P; Hussain ST; Perera D; Schaeffter T; Spaan JA; Siebes M; Nagel E; Chiribiri A
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1082-92. PubMed ID: 25812572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring myocardial salvage.
    Bøtker HE; Kaltoft AK; Pedersen SF; Kim WY
    Cardiovasc Res; 2012 May; 94(2):266-75. PubMed ID: 22311720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction.
    Matsumoto H; Matsuda T; Miyamoto K; Shimada T; Mikuri M; Hiraoka Y
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):610-8. PubMed ID: 21679895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Area at Risk Quantification by Cardiac Magnetic Resonance According to the Myocardial Infarction Territory.
    Fernández-Friera L; García-Ruiz JM; García-Álvarez A; Fernández-Jiménez R; Sánchez-González J; Rossello X; Gómez-Talavera S; López-Martín GJ; Pizarro G; Fuster V; Ibáñez B
    Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):323-330. PubMed ID: 27592277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.
    Wagner A; Mahrholdt H; Holly TA; Elliott MD; Regenfus M; Parker M; Klocke FJ; Bonow RO; Kim RJ; Judd RM
    Lancet; 2003 Feb; 361(9355):374-9. PubMed ID: 12573373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardium at risk can be determined by ex vivo T2-weighted magnetic resonance imaging even in the presence of gadolinium: comparison to myocardial perfusion single photon emission computed tomography.
    Ubachs JF; Engblom H; Koul S; Kanski M; Andersson P; van der Pals J; Carlsson M; Erlinge D; Arheden H
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):261-8. PubMed ID: 22822155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Area at risk can be assessed by iodine-123-meta-iodobenzylguanidine single-photon emission computed tomography after myocardial infarction: a prospective study.
    Hedon C; Huet F; Ben Bouallegue F; Vernhet H; Macia JC; Cung TT; Leclercq F; Cade S; Cransac F; Lattuca B; Vandenberghe D; Bourdon A; Benkiran M; Vauchot F; Gervasoni R; D'estanque E; Mariano-Goulart D; Roubille F
    Nucl Med Commun; 2018 Feb; 39(2):118-124. PubMed ID: 29194288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance.
    Raman SV; Shah M; McCarthy B; Garcia A; Ferketich AK
    Am Heart J; 2006 Mar; 151(3):736-44. PubMed ID: 16504643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of angiographic, electrocardiographic and MRI methods to assess the area at risk in acute myocardial infarction.
    Versteylen MO; Bekkers SC; Smulders MW; Winkens B; Mihl C; Winkens MH; Leiner T; Waltenberger JL; Kim RJ; Gorgels AP
    Heart; 2012 Jan; 98(2):109-15. PubMed ID: 21930725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.